Contribution of sex hormones to gender differences in schizophrenia: A review

Asian Journal of Psychiatry
Tricia L da Silva, Arun V Ravindran

Abstract

Female patients with schizophrenia tend to have a more benign course and better outcomes than males. One proposed explanation is the differential influence of male and female sex hormones, including estrogen, progesterone, testosterone, and dehydroepiandrosterone (DHEA) and its sulfate (DHEAS). Such benefit may be mediated by their effects on neurotransmitters and neuroprotection. Besides altered estrogen and DHEA/DHEAS levels in female patients, data is equivocal on hormonal differences between patients and controls. However, several reports note a mostly negative correlation between estrogen levels and symptom severity in both genders, and a positive correlation between estrogen levels and neurocognition but mainly in females. Adjunctive estrogen appears to improve symptoms in both genders. Progesterone levels have inconsistent links to symptom severity in both genders, and correlate positively with neurocognition but only in males. Estrogen-progesterone combination shows preliminary benefits as augmentation for both symptoms and neurocognition in females. Testosterone levels correlate inversely with negative symptoms in males and have inconsistent associations with neurocognition in both genders. Testosterone augmentation re...Continue Reading

References

Oct 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·L F Saugstad
Nov 1, 1996·Harvard Review of Psychiatry·V HendrickV K Burt
Mar 8, 2000·Acta Psychiatrica Scandinavica·K N ThompsonA A Sergejew
Apr 19, 2000·Journal of Cognitive Neuroscience·R Cabeza, L Nyberg
Jul 11, 2000·Acta Psychiatrica Scandinavica. Supplementum·A Leung, P Chue
Aug 2, 2000·Archives of General Psychiatry·R E GurR C Gur
Oct 21, 2000·Progress in Neurobiology·L M Garcia-SeguraL L DonCarlos
Nov 9, 2000·Psychoneuroendocrinology·T J HuberU Schneider
Mar 10, 2001·Progress in Neurobiology·M K Osterlund, Y L Hurd
Mar 23, 2001·Acta Psychiatrica Scandinavica. Supplementum·A Riecher-Rössler, H Häfner
Jun 30, 2001·The American Journal of Psychiatry·A L HoffT E Nordahl
Feb 2, 2002·The American Journal of Psychiatry·Philip R SzeszkoRobert M Bilder
Mar 23, 2002·Journal of Clinical Psychopharmacology·Shubulade SmithVeronica O'Keane
May 15, 2002·Psychiatry Research·Jill M GoldsteinGary Tollefson
Feb 18, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·D S HarrisV I Reus
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shahin AkhondzadehAbbas Kamalipour
Dec 25, 2003·Schizophrenia Research·Raimo K R Salokangas
Mar 9, 2004·The Journal of Clinical Psychiatry·Maria A RettenbacherW Wolfgang Fleischhacker
Mar 11, 2004·Acta Psychiatrica Scandinavica·T J HuberH M Emrich
Mar 17, 2004·Biological Psychiatry·Raquel E GurRuben C Gur
Sep 11, 2004·Psychoneuroendocrinology·Thomas J HuberHinderk M Emrich
Sep 11, 2004·Journal of Psychopharmacology·R HalariT Sharma
Jan 29, 2005·Annals of the New York Academy of Sciences·R O GoyalA G Alias
Feb 24, 2005·Journal of Psychiatric Research·Flavia di MicheleGianfranco Spalletta
May 5, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael RitsnerAbraham Weizman
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Jun 9, 2005·The Journal of Neuropsychiatry and Clinical Neurosciences·Y Kaneda, T Ohmori
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael RitsnerAbraham Weizman
Sep 15, 2005·Journal of Psychiatric Research·Henry SilverYiftah Finkelstein
Dec 13, 2005·Clinical Neuropharmacology·Rael D StrousAbraham Weizman
Jun 10, 2006·Neuropsychobiology·Young-Hoon KoSeung-Hyun Kim
Aug 1, 2006·Hormones and Behavior·Jill M Goldstein
Sep 13, 2006·The Journal of Clinical Psychiatry·Michael F Green
Nov 25, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael RitsnerAbraham Weizman
Dec 8, 2006·Schizophrenia Research·Deborah J WalderJill M Goldstein

❮ Previous
Next ❯

Citations

Feb 11, 2016·Biology of Sex Differences·Farshad A MansouriHelena Parkington
Nov 26, 2015·International Journal of Molecular Sciences·Silvia Hoirisch-Clapauch, Antonio E Nardi
Mar 5, 2016·Nature Reviews. Drug Discovery·Mark J MillanDaniel Weinberger
May 4, 2016·Psychopharmacology·Inga Griskova-BulanovaOsvaldas Ruksenas
Jul 18, 2016·Comprehensive Psychiatry·Süheyla Doğan BulutOlga Güriz
Jan 29, 2017·Expert Opinion on Pharmacotherapy·Bettina LangeJ Malte Bumb
Dec 17, 2016·International Journal of Tryptophan Research : IJTR·J de BieG J Guillemin
Oct 31, 2017·International Journal of Psychiatry in Clinical Practice·Usama AsifFahad Saleem
May 17, 2018·Archives of Women's Mental Health·Anita Riecher-RösslerJayashri Kulkarni
Dec 12, 2019·International Journal of Psychiatry in Clinical Practice·Petros PetrikisPetros Skapinakis
Nov 7, 2018·Translational Psychiatry·Lin WanRena Li
Nov 30, 2018·The Psychiatric Quarterly·Mary V Seeman
May 6, 2020·Neuropsychiatric Disease and Treatment·Anastasiia S BoikoSvetlana A Ivanova
Jan 6, 2021·International Journal of Molecular Sciences·Wu Jeong HwangJun Soo Kwon
Jan 14, 2021·Psychiatry Research·Francesca MartiniRoberto Cavallaro
Mar 31, 2018·Molecular and Cellular Neurosciences·Kirsten C SvaneBonnie L Firestein
Feb 10, 2021·Current Opinion in Psychiatry·Bodyl A BrandIris E C Sommer
Apr 20, 2021·Journal of Psychiatric Research·Israel KriegerDana Tzur Bitan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.